Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Stem Cell Therapy for Tissue Regeneration

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...

Mesenchymal Stem Cells

Mesenchymal Stem Cells

Mesenchymal stem cells (MSCs) are adult stem cells that can differentiate into most connective tissue cell types, except for hematopoietic cells, depending upon the source of MSCs. For example, bone-marrow-derived MSCs (BM-MSCs) can differentiate into osteocytes, hepatocytes, and pancreatic and neuronal cells. MSCs can be isolated from various sources such as bone marrow, placenta, adipose tissue, teeth, and Wharton’s jelly, a gelatinous substance in the umbilical cord. The ease of their access...

Stem Cell Culture

Stem Cell Culture

Stem cell research aims to find ways to use stem cells to regenerate and repair cellular damage. Over time, most adult cells undergo the wear and tear of aging and lose their ability to divide and repair themselves. Stem cells do not display a particular morphology or function. Adult stem cells, which exist as a small subset of cells in most tissues, keep dividing and can differentiate into a number of specialized cells generally formed by that tissue. These cells enable the body to renew and...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Long-Term Outcomes of a Self-Expanding Transcatheter Heart Valve.

Structural heart : the journal of the Heart Team·2026

Same author

Preoperative stress markers as predictors of postoperative neuropsychological disorders in cardiac surgery patients: protocol for a single-centre prospective observational study (CAVALIR).

BMJ open·2026

Same author

Direct, transapical, echocardiography-guided laceration of an Alfieri stitch to facilitate transcatheter mitral valve implantation: Keeping it simple.

JTCVS structural and endovascular·2026

Same author

Coordinated Developmental Remodeling of IGF/FGF-MAPK Signaling and Cytoskeletal Plasticity Coincides with the Loss of Cardiac Regenerative Capacity.

Cells·2026

Same author

An Inducible hiPSC-Derived Human Podocyte Model for Functional Analysis of TRPC6 Variants Associated with FSGS.

Cells·2026

Same author

Three-Phase Serum Concentration Kinetics of FGF23 in a Clinical Model of Acute Myocardial Infarction.

Cells·2026

Search research articles

Related Experiment Video

Updated: Jun 6, 2026

Isolation and Characterization of Cardiac Mesenchymal Stromal Cells from Endomyocardial Bioptic Samples of Arrhythmogenic Cardiomyopathy Patients

Isolation and Characterization of Cardiac Mesenchymal Stromal Cells from Endomyocardial Bioptic Samples of Arrhythmogenic Cardiomyopathy Patients

Published on: February 28, 2018

Mesenchymal stem cells for cardiac cell therapy.

Yeong-Hoon Choi¹, Andreas Kurtz, Christof Stamm

¹Heart Center of the University of Cologne, Cologne, Germany.

Human Gene Therapy

|November 11, 2010

Summary

Mesenchymal stem cells (MSCs) show promise for heart failure regeneration, moving beyond limited hematopoietic and endothelial progenitor cell therapies. Preclinical and clinical studies are evaluating MSCs for cardiac repair and improved patient outcomes.

More Related Videos

Assessing Stem Cell DNA Integrity for Cardiac Cell Therapy

Assessing Stem Cell DNA Integrity for Cardiac Cell Therapy

Published on: January 25, 2019

Intramyocardial Cell Delivery: Observations in Murine Hearts

Intramyocardial Cell Delivery: Observations in Murine Hearts

Published on: January 24, 2014

Related Experiment Videos

Last Updated: Jun 6, 2026

Isolation and Characterization of Cardiac Mesenchymal Stromal Cells from Endomyocardial Bioptic Samples of Arrhythmogenic Cardiomyopathy Patients

Isolation and Characterization of Cardiac Mesenchymal Stromal Cells from Endomyocardial Bioptic Samples of Arrhythmogenic Cardiomyopathy Patients

Published on: February 28, 2018

Assessing Stem Cell DNA Integrity for Cardiac Cell Therapy

Assessing Stem Cell DNA Integrity for Cardiac Cell Therapy

Published on: January 25, 2019

Intramyocardial Cell Delivery: Observations in Murine Hearts

Intramyocardial Cell Delivery: Observations in Murine Hearts

Published on: January 24, 2014

Area of Science:

Cardiovascular Research
Regenerative Medicine
Stem Cell Biology

Background:

Heart failure remains a leading cause of mortality despite medical and surgical advancements.
Myocardial infarction is the primary cause of heart failure, with current treatments offering only palliative relief.
The traditional view of the heart lacking regenerative capacity is being challenged by emerging cell-based therapies.

Purpose of the Study:

To review preclinical data on mesenchymal stem cells (MSCs) in heart disease models.
To appraise the clinical experience with MSCs for cardiac cell therapy.
To explore the potential of MSCs in regenerating damaged myocardium.

Main Methods:

Summary of preclinical studies involving MSCs in animal models of cardiac disease.
Analysis of published clinical trials investigating MSCs for heart conditions.
Evaluation of MSC properties including self-renewal and multilineage differentiation potential.

Main Results:

Hematopoietic stem cells and endothelial progenitor cells demonstrate limited regenerative capacity in human hearts.
Mesenchymal stem cells (MSCs) are being actively investigated in preclinical and clinical settings for cardiac repair.
MSCs possess self-renewal and differentiation capabilities, with specific surface markers and in vitro differentiation potential defining their characteristics.

Conclusions:

Mesenchymal stem cells (MSCs) represent a promising avenue for cardiac regeneration, offering potential beyond earlier stem cell types.
Ongoing research and clinical trials are crucial for understanding the full therapeutic potential of MSCs in heart failure.
The definition and characterization of MSCs are critical for consistent and effective application in cardiac cell therapy.